Your browser doesn't support javascript.
loading
EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses BRCA1-mutated breast cancer.
Asik, Elif; Akpinar, Yeliz; Caner, Ayse; Kahraman, Nermin; Guray, Tulin; Volkan, Murvet; Albarracin, Constance; Pataer, Apar; Arun, Banu; Ozpolat, Bulent.
Afiliación
  • Asik E; Department of Experimental Therapeutics, The University of Texas-MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Akpinar Y; Department of Biotechnology, Middle East Technical University, Ankara 06800, Turkey.
  • Caner A; Department of Chemistry, Middle East Technical University, Ankara 06800, Turkey.
  • Kahraman N; Department of Chemistry, Kirsehir Ahi Evran University, Kirsehir 40100, Turkey.
  • Guray T; Department of Experimental Therapeutics, The University of Texas-MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Volkan M; Department of Experimental Therapeutics, The University of Texas-MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Albarracin C; Department of Biotechnology, Middle East Technical University, Ankara 06800, Turkey.
  • Pataer A; Department of Chemistry, Middle East Technical University, Ankara 06800, Turkey.
  • Arun B; Department of Pathology, Division of Pathology/Lab Medicine, MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Ozpolat B; Department of Thoracic Surgery, MD Anderson Cancer Center, Houston, TX 77054, USA.
Nanomedicine (Lond) ; 14(17): 2315-2338, 2019 09.
Article en En | MEDLINE | ID: mdl-31432749
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteína BRCA1 / ARN Interferente Pequeño / Quinasa del Factor 2 de Elongación / Tratamiento con ARN de Interferencia Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Nanomedicine (Lond) Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteína BRCA1 / ARN Interferente Pequeño / Quinasa del Factor 2 de Elongación / Tratamiento con ARN de Interferencia Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Nanomedicine (Lond) Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos